Macrophage Subtypes in Brainstem Catecholamine Regions in Healthy Ageing and Across Parkinson’s Disease.
Objective: To assess macrophages in the human brainstem in healthy ageing and during Parkinson’s disease (PD). Background: PD is the second most common neurodegenerative disorder…Case of Head Drop as an Adverse Drug Reaction to Dopamine Agonists and Regulatory Evaluation
Objective: RLS can be treated with NEDA, generally in lower dosing than PD. We review a case of HD possibly caused by the DA treatment…Immunological characteristics of Parkinson’s disease by clinical form and stage
Objective: To analysed of IL-10 concentrations in serum of patients with PD. Background: IL-10 is a key pro-inflammatory cytokine involved in the regulation of microglia…Restoring Dopaminergic Function: iPSC-derived MSCs Show Therapeutic Promise in Parkinson’s Disease Rat Model
Objective: This study looked into the therapeutic potential of human induced pluripotent stem cell derived mesenchymal stromal cells (iMSCs) in a MPTP induced Parkinson’s disease rat model. Background: PD…Levels of cytokines in the cerebrospinal fluid of patients depending on the stages of Parkinson’s disease
Objective: To study of cytokine levels in serum and cerebrospinal fluid of patients with different stages of PD. Background: The clinical course of Parkinson's disease…Electroacupuncture Restores Cortico-striatal Synaptic Plasticity by Promoting STEP61 against 6-OHDA Induced Extrasynaptic NMDAR/TRPM4 Complex
Objective: This study investigated whether electroacupuncture (EA) exerted neuroprotection by regulating the physical coupling of extrasynaptic N-methyl-D-aspartate receptor (NMDAR) to the transient receptor potential (TRP)…Role and significance of C-reactive protein in stages of Parkinson’s disease
Objective: To сomparative analysis of the amount of CRP in the blood serum of patients according to the stages of PD. Background: C-reactive protein (CRP)…Nigrostriatal Dopaminergic Impairment Patterns in Idiopathic Normal Pressure Hydrocephalus Identified by 18F-FP-DTBZ PET: a 5-Year Longitudinal Study
Objective: To delineate the pattern of nigrostriatal dopaminergic dysfunction in iNPH, explore inter-individual heterogeneity, and evaluate its association with clinical features and long-term outcomes. Background:…Levels of IgA and IgG concentrations by stage of Parkinson’s disease
Objective: To study of IgA and IgG levels cerebrospinal fluid of patients with different stages of PD. Background: In the clinical course of Parkinson's disease…Neuroprotective Effects of Thymol in MPTP-Induced Parkinson’s Disease Model in Rats: Molecular Docking, Behavioral, Biochemical, and Histological Investigations
Objective: This study aimed to investigate the neuroprotective potential of thymol in an MPTP-induced Parkinson’s disease (PD) model in rats, focusing on its ability to…
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 17
- Next Page »